WallStreetZenWallStreetZen

NASDAQ: MNPR
Monopar Therapeutics Stock Ownership - Who owns Monopar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monopar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew CittadineChief Operating Officer2025-12-311,889$65.30
$123.35kSell
Chandler RobinsonChief Executive Officer2025-12-312,558$65.30
$167.04kSell
Quan Anh VuChief Financial Officer2025-12-261,500$69.95
$104.93kBuy
Arthur J. KlausnerDirector2025-12-184,660$67.06
$312.50kSell
Arthur J. KlausnerDirector2025-12-18461$68.09
$31.39kSell
Andrew CittadineChief Operating Officer2025-09-301,896$81.67
$154.85kSell
Chandler RobinsonChief Executive Officer2025-09-302,646$81.67
$216.10kSell
Tactic Pharma LLCChief Executive Officer2025-09-24550,229$63.61
$35.00MSell
Chandler RobinsonChief Executive Officer2025-07-1416,800$40.00
$672.02kSell
Chandler RobinsonChief Executive Officer2025-07-1416,800$0.01
$84.00Buy

1 of 2

MNPR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MNPR insiders and whales buy or sell their stock.

MNPR Shareholders

What type of owners hold Monopar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arthur J. Klausner137.30%9,174,944$564.53MInsider
Michael J. 1. Brown71.91%4,805,470$295.68MInsider
Tactic Pharma LLC65.59%4,383,299$269.70MInsider
Janus Henderson Group PLC19.71%1,317,410$81.06MInstitution
Ra Capital Management LP9.98%667,207$41.05MInstitution
Adage Capital Partners GP LLC9.57%639,467$39.35MInstitution
Chandler Robinson5.35%357,744$22.01MInsider
Saturn V Capital Management LP4.87%325,701$20.04MInstitution
Vanguard Group Inc4.40%293,816$18.08MInstitution
Blackrock Inc3.81%254,857$15.68MInstitution

1 of 3

MNPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MNPR22.32%77.68%Net SellingNet Selling
AUTL52.34%0.00%
BNTC91.68%8.32%Net BuyingNet Buying
AKBA44.14%8.15%Net SellingNet Selling
PRTC0.04%0.00%
View Top Biotech Stocks

Monopar Therapeutics Stock Ownership FAQ

Who owns Monopar Therapeutics?

Monopar Therapeutics (NASDAQ: MNPR) is owned by 82.64% institutional shareholders, 287.67% Monopar Therapeutics insiders, and 0.00% retail investors. Arthur J. Klausner is the largest individual Monopar Therapeutics shareholder, owning 9.17M shares representing 137.30% of the company. Arthur J. Klausner's Monopar Therapeutics shares are currently valued at $552.97M.

If you're new to stock investing, here's how to buy Monopar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.